This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Receptos, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: The Innovations of Roger Bakale
Introduction
Roger Bakale is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate sphingosine-1-phosphate receptors. With a total of 4 patents to his name, Bakale's work has the potential to impact various medical conditions.
Latest Patents
Among his latest patents, Bakale has developed compounds that serve as modulators of the sphingosine-1-phosphate receptor. These compounds are characterized by a specific structure defined in his patent documents, which includes pharmaceutically acceptable salts, homologs, hydrates, or solvates. The utility of these compounds lies in their application for treating medical conditions where activation of this receptor is indicated.
Career Highlights
Roger Bakale is currently associated with Receptos, Inc., where he continues to innovate and contribute to the field. His work focuses on advancing therapeutic options through the development of novel compounds. His expertise in receptor modulation has positioned him as a key figure in pharmaceutical research.
Collaborations
Bakale has collaborated with notable colleagues such as Jeff Schkeryantz and Maurice Marsini. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented compounds.
Conclusion
Roger Bakale's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as an influential inventor. His work in receptor modulation is paving the way for new treatment options in medicine.